Several case reports have been published showing the efficacy of PD-1 inhibitors in HIV patients in lung cancer [12–14], Hodgkin's lymphoma [15], melanoma [16, 17], and anal cancer [18]. This evidence concerns the gene PDCD1 and lung cancer.